Rabeeah Iman, Billington Elizabeth, Nal Béatrice, Sadeyen Jean-Remy, Pathan Ansar A, Iqbal Munir, Temperton Nigel J, Zipfel Peter F, Skerka Christine, Kishore Uday, Shelton Holly
Pirbright Institute, Woking, United Kingdom.
Biosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom.
Front Immunol. 2024 Apr 18;15:1352022. doi: 10.3389/fimmu.2024.1352022. eCollection 2024.
The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects "self" cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the significance of which for the virus or host is yet to be elucidated.
补体系统是一种针对微生物感染的固有免疫机制。它涉及一系列效应分子,这些分子通过经典途径、凝集素途径和替代途径被激活。因此,许多病原体在其结构中结合或纳入补体途径的宿主负调节因子作为一种逃避机制。因子H(FH)是补体替代途径的负调节因子,可保护宿主的“自身”细胞免受非特异性补体攻击。已证明FH可结合包括人类甲型流感病毒(IAV)在内的病毒。除了参与补体激活的调节外,FH还被证明自身具有一系列功能,包括与病原体的直接相互作用。在这里,我们表明人类FH可以直接结合人类和禽类来源的IAV,并且这种相互作用是通过IAV表面糖蛋白血凝素(HA)介导的。HA结合到FH结构上常见的病原体结合位点、补体控制蛋白模块CCP 5-7和CCP 15-20上。FH与H1和H3的结合表明,这种相互作用与两种HA的受体结合位点重叠,但H3 HA的结合位点比H1 HA更广泛。HA-FH相互作用阻碍了H1N1和H3N2 IAV毒株的初始进入,但其对人类肺细胞中病毒多轮复制的影响具有毒株特异性。用FH预孵育可显著抑制H3N2病毒与细胞的结合,而对于人类H1N1、禽类H9N2和H5N3 IAV毒株,其复制速率和子代病毒释放没有变化。我们已经绘制了FH与IAV之间的相互作用图谱,其对病毒或宿主的意义尚待阐明。